Levocarnitine for the treatment of valproic acid-induced hyperammonemic encephalopathy in children: the experience of a large, tertiary care pediatric hospital and a poison center
Saba GLP-1 has become a staple in my routine, and I recommend it to anyone looking for support with appetite control, weight management, and overall wellness
However, some patients may experience symptomatic low blood pressure, particularly when combined with antihypertensive medications, during significant weight loss, or when dehydrated from gastrointestinal side effects
Anyone who suspects they are experiencing a side effect from any medicine or unlicensed compound should report it to the MHRA via the Yellow Card scheme at and contact their GP promptly
We are still early in understanding exactly which patients benefit most, how much of the effect is independent of weight loss, and how GLP-1s compare with other metabolic interventions
Engineering new peptides with desired selectivity profiles requires time-consuming and expensive cycles of design-make-test-analyse (DMTA) work